Skip to main content

Table 1 Description of the study population (n = 305)

From: Oral human Papillomavirus DNA detection in HIV-positive men: prevalence, predictors, and co-occurrence at anal site

Demographics

Age, median years (IQR)

44.7 (37.4–51.0)

Caucasian ethnicity, n (%)

283 (92.8)

Clinical, HIV- and cART-related factors

Main route for HIV acquisition, n (%)

 

 Homosexual/ Bisexual

262 (85.9)

 Heterosexual

27 (8.9)

 IVDU

4 (1.3)

 Other or unknown

12 (3.9)

cART, n (%)

289 (94.8)

Time on cART, median years (IQR)

4.4 (1.9–9.3)

HIV RNA, n (%)

 Not detected

221 (72.5)

 Detectable <40 copies/ml

47 (15.4)

  > 40 copies/ml

37 (12.1)

CD4+ cell count, n (%)

  ≥ 500/μl

243 (79.7)

 201–499/μl

54 (17.7)

  ≤ 200/μl

8 (2.6)

Patient-reported health behaviours

Cigarette smoking, n (%)

 Never

107 (35.1)

 Former

53 (17.4)

 Current

145 (47.5)

Use of recreational drug, n (%)

 Never

224 (73.4)

 Former

34 (11.1)

 Current

47 (15.4)

Current alcohol consumption (>3 units/daily), n (%)

11 (3.6)

Patient-reported sexual behaviours

Number of lifetime sexual partners, median (IQR)

 Heterosexual males

10 (5.5–35)

 Bi-sexual males

100 (30–300)

 Homosexual males

100 (20–400)

Receptive oral sex ever, n (%)

275 (90.2)

Sexual activity in previous 12 months, n (%)

284 (93.1)

Type of sexual partner in previous 12 months, n (%)a

 Heterosexual

31 (10.9)

 Bi-sexual

44 (15.5)

 Homosexual

209 (73.6)

Number of partners in previous 12 months, median (IQR)

 Heterosexual

1 (1–2)

 Bi-sexual

7 (3–19)

 Homosexual

4 (1–10)

Previous or current anal condylomatosis, n (%)

112 (36.7)

  1. cART: combination antiretroviral therapy; IVDU: intravenous drug use
  2. apercentages calculated on 284 sexually active men (93.1% of the total) in the last 12 months